09:05 AM EDT, 04/02/2024 (MT Newswires) -- Health care stocks were leaning lower premarket Tuesday, with the Health Care Select Sector SPDR Fund (XLV) retreated 1%, while the iShares Biotechnology ETF ( IBB ) was flat.

Verve Therapeutics ( VERV ) fell more than 36% after the company paused enrollment in its Heart-1 clinical trial following adverse events in one of the dosed patients.

Acorda Therapeutics ( ACOR ) tumbled over 76% after saying it has signed an agreement to sell substantially all its assets to Merz Therapeutics for $185 million.

Humana (HUM) was down almost 11%, UnitedHealth Group ( UNH ) declined more than 4%, while CVS Health ( CVS ) was about 6% lower following the Centers for Medicare and Medicaid Services' declaration of a 3.7% average revenue boost for Medicare Advantage plans in 2025.